The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

The ASX200 is set to trade slightly higher today, with futures almost flat – up just 0.08% -near 8.30am AEST.

Stocks in the US experienced a volatile session on Thursday as investors await news of a crucial jobs report for August.

The S&P 500 and the Dow Jones dropped 0.3% and 0.5%, respectively, while the Nasdaq100 made slight gains after initially moving up more than 1%.

In the ASX, debt-laden Synlait Milk Ltd (ASX:SM1) was told that a Takeovers Panel would take no action over the company’s recapitalisation plan after founder John Penno had complained about the deal, which would see Bright Dairy acquire a 65% stake in Synlait (up from its current 39.01% investment.

The deal is to be approved at a shareholder’s meeting on September 18.

Axel REE Ltd (ASX:AXL) is about to kick off an exploration program looking for niobium at its Itiquira Project in Brazil.

And telecommunications service provider Vonex Ltd (ASX:VN8) has responded to a takeover offer from Swoop Holdings Ltd (ASX:SWP), with the board advising investors to take no action, considering that a previous Scheme of Arrangement offer from MaxoTel is the superior option.

In commodities where prices are in USD, iron Ore is fetching $92.93 per tonne in Singapore, a barrel of Brent Crude is currently worth just over $72.79, gold is at $2,516 per ounce, and US natgas futures are fetching $2.26 per gigajoule.

In forex, the Aussie continues to buy 67 US cents.

More From The Market Online
Market Close Graphic

ASX Market Close: Another reversal as just-green Oz markets ignore US dive | Jan 3, 2024

The Aussie bourse has defied morning expectations for the second time in as many days, closing out all but flat with a 0.
A Red Sky Energy rig out in the ocean.

Red Sky Energy bleeds more than 18% after ‘landmark’ Angola block entry

Red Sky Energy was ready to pop champagne after being awarded 35% in a "transformative" Angola…
A patient being dosed with Imugene Limited testing materials.

First Aussie doses bring Imugene major step closer to ‘quicker, cheaper’ non-Hodgkin’s lymphoma care

Imugene Limited (ASX:IMU) has hit its first important milestone in 2025, dosing its first Australian patient with its allogenic
A market trading board with ASX marked on the side.

‘Shine a light’: ASX to get more aggressive on companies ‘not up to scratch’ on disclosures

The Australian Securities Exchange (ASX:ASX) will be taking poor disclosure from market-listed companies far more seriously through this next